Levosimendan meta-analyses: Is there a pattern in the effect on mortality?  P. Pollesello, J. Parissis, M. Kivikko, V.-P. Harjola  International Journal of Cardiology  Volume 209, Pages 77-83 (April 2016) DOI: 10.1016/j.ijcard.2016.02.014 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Effect of levosimendan on survival. Meta-analysis of the results of the phase II and III clinical trials considered in the regulatory process. These trials included the dose-finding study by Slawsky et al. [29], the dose-escalation and withdrawal study by Nieminen et al. [30], the LIDO study by Follath et al. [31], the RUSSLAN study by Moiseyev et al. [32], the SURVIVE study by Mebazaa et al. [33], and the REVIVE (I and II) study by Packer et al. [34]. #Pooled statistics was calculated using the Cochran–Mante–Haenszel test, controlling for the study. International Journal of Cardiology 2016 209, 77-83DOI: (10.1016/j.ijcard.2016.02.014) Copyright © 2016 The Authors Terms and Conditions